Texas Attorney General Files Lawsuit Against Tylenol Producers Over Autism Spectrum Claims

Courtroom Case
Ken Paxton, who supports former President Trump who is running for US Senate, alleged the drug companies of hiding the risks of acetaminophen

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of acetaminophen, alleging the companies concealed potential risks that the drug posed to children's cognitive development.

The court filing follows thirty days after Donald Trump promoted an unproven link between taking Tylenol - alternatively called acetaminophen - while pregnant and autism in young ones.

Paxton is suing the pharmaceutical giant, which once produced the drug, the only pain reliever approved for women during pregnancy, and Kenvue, which currently produces it.

In a statement, he stated they "misled consumers by profiting off of pain and pushing pills regardless of the potential hazards."

The company asserts there is no credible evidence connecting acetaminophen to autism.

"These corporations lied for decades, knowingly endangering millions to boost earnings," Paxton, from the Republican party, declared.

The company commented that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the health of American women and children."

On its official site, the company also stated it had "consistently assessed the relevant science and there is lacking reliable evidence that shows a proven link between using paracetamol and autism."

Groups speaking for doctors and medical practitioners concur.

The American College of Obstetricians and Gynecologists has said paracetamol - the main ingredient in Tylenol - is one of the few options for pregnant women to manage pain and elevated temperature, which can present serious health risks if not addressed.

"In over twenty years of investigation on the utilization of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the use of paracetamol in any stage of gestation causes brain development issues in offspring," the association commented.

This legal action mentions current declarations from the previous government in arguing the drug is potentially dangerous.

In recent weeks, the former president generated worry from health experts when he instructed pregnant women to "resist strongly" not to consume acetaminophen when sick.

Federal regulators then published an announcement that medical professionals should consider limiting the use of Tylenol, while also stating that "a proven link" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in spring to undertake "comprehensive study program" that would establish the cause of autism in a matter of months.

But authorities cautioned that discovering a sole reason of autism - considered by experts to be the outcome of a intricate combination of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of lifelong neurodivergence and disability that influences how people experience and engage with the environment, and is identified using doctors' observations.

In his court filing, the attorney general - who supports Trump who is seeking federal office - claims the manufacturer and Johnson & Johnson "willfully ignored and tried to quiet the science" around acetaminophen and autism.

This legal action seeks to make the firms "destroy any promotional materials" that states acetaminophen is safe for expectant mothers.

The Texas lawsuit mirrors the grievances of a group of guardians of minors with autism spectrum disorder and ADHD who sued the makers of acetaminophen in recently.

The court dismissed the legal action, stating investigations from the family's specialists was inconclusive.

Mike Mcclure
Mike Mcclure

Elara is an experienced HR strategist with a passion for connecting companies with exceptional talent worldwide.